Japan’s LDP Medical Commission Approves Pharmaceutical Law Amendment And Regenerative Medicine Proposal
This article was originally published in PharmAsia News
Executive Summary
The Japan LDP Health Committee and Subcommittee on Pharmaceutical Affairs approved the Pharmaceutical Law amendment and new Regenerative Medicine law proposed by MHLW April 26.